WMA Declaration of Helsinki – Ethical Principles f... ...
Drug candidate slows motor neuron disease progress...
NAD⁺ restores memory in Alzheimer's disease models...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Ask the Heart Doctor | Heart Valve Disease and Sur...
Young adults commonly mix cannabis with nicotine and tobacco...
April 06,2026
You finally got a doctor's appointment. Here's how to get th...
April 05,2026
Thick melanoma tumors may be linked to poorer survival than ...
April 04,2026
Study demonstrates how pediatric integrative medicine can be...
April 03,2026
Sodium bicarbonate fails to boost survival in patients with ...
April 02,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Announcement of the 2025 Nobel Prize in ...
Can a twice-a-year shot help end the HIV...
Reprogramming Stem Cells Could Cure Type...
Dr. Fauci among hundreds who've contract...
More News
Visual mismatch negativity identified as a mechanism of Parkinson's disease psychosis

Visual mismatch negativity identified as a mechanism of Parkinson's disease psychosis

byKing's College LondonGraphical Abstract. Credit:Brain Communications(2024). DOI: 10.1093/braincomms/fcae291Reduced brain activity responding to unpredicted visual changes is a
Neurology October 16,2024
Visual mismatch negativity identified as a mechanism of Parkinson's disease psychosis

Visual mismatch negativity identified as a mechanism of Parkinson's disease psychosis

byKing's College LondonGraphical Abstract. Credit:Brain Communications(2024). DOI: 10.1093/braincomms/fcae291Reduced brain activity responding to unpredicted visual changes is a
Neurology October 16,2024
Deep brain stimulation shows immediate improvement in arm and hand function post-brain injury, study finds

Deep brain stimulation shows immediate improvement in arm and hand function post-brain injury, study finds

byUniversity of PittsburghCredit: Unsplash/CC0 Public DomainDeep brain stimulation may provide immediate improvement in arm and hand strength and function weakened by traumatic brain injury or s
Neurology October 16,2024
Deep brain stimulation shows immediate improvement in arm and hand function post-brain injury, study finds

Deep brain stimulation shows immediate improvement in arm and hand function post-brain injury, study finds

byUniversity of PittsburghCredit: Unsplash/CC0 Public DomainDeep brain stimulation may provide immediate improvement in arm and hand strength and function weakened by traumatic brain injury or s
Neurology October 16,2024
Hearing loss can raise risks for cognitive decline, study shows

Hearing loss can raise risks for cognitive decline, study shows

by Carole Tanzer MillerA new, large study from France underscores the link between adult hearing loss and dementia."Given the major burden ofcognitive declineand the absence of curati
ENT & HN October 16,2024
Hearing loss can raise risks for cognitive decline, study shows

Hearing loss can raise risks for cognitive decline, study shows

by Carole Tanzer MillerA new, large study from France underscores the link between adult hearing loss and dementia."Given the major burden ofcognitive declineand the absence of curati
ENT & HN October 16,2024
Study finds no uniform brain shrinkage pattern in Alzheimer's

Study finds no uniform brain shrinkage pattern in Alzheimer's

byUniversity College LondonMapped is the proportion of participants with a high rate of atrophy in cortical (left) and subcortical (right) areas. AD, Alzheimer's disease; MCI, mild cognitive
Neurology October 16,2024
Study finds no uniform brain shrinkage pattern in Alzheimer's

Study finds no uniform brain shrinkage pattern in Alzheimer's

byUniversity College LondonMapped is the proportion of participants with a high rate of atrophy in cortical (left) and subcortical (right) areas. AD, Alzheimer's disease; MCI, mild cognitive
Neurology October 16,2024
Neanderthoids and space brains: Stem cell researcher pushes the boundaries of neuroscience

Neanderthoids and space brains: Stem cell researcher pushes the boundaries of neuroscience

by Genomic PressAlysson R. Muotri, Ph.D., University of California, San Diego, U.S. Credit:Brain Medicine(2024). https://doi.org/10.61373/bm024k.0082In an interviewpublishedin&
Neurology October 16,2024
Neanderthoids and space brains: Stem cell researcher pushes the boundaries of neuroscience

Neanderthoids and space brains: Stem cell researcher pushes the boundaries of neuroscience

by Genomic PressAlysson R. Muotri, Ph.D., University of California, San Diego, U.S. Credit:Brain Medicine(2024). https://doi.org/10.61373/bm024k.0082In an interviewpublishedin&
Neurology October 16,2024
Brain molecule reverses movement deficits of Parkinson's, offering new therapeutic target

Brain molecule reverses movement deficits of Parkinson's, offering new therapeutic target

byUniversity of California, IrvineCredit: Pixabay/CC0 Public DomainA research team from the University of California, Irvine is the first to reveal that a molecule in the brain—ophthalmic acid—u
Neurology October 16,2024
Brain molecule reverses movement deficits of Parkinson's, offering new therapeutic target

Brain molecule reverses movement deficits of Parkinson's, offering new therapeutic target

byUniversity of California, IrvineCredit: Pixabay/CC0 Public DomainA research team from the University of California, Irvine is the first to reveal that a molecule in the brain—ophthalmic acid—u
Neurology October 16,2024
Turning brain cells on using the power of light: Researchers refine noninvasive method of bioluminescent optogenetics

Turning brain cells on using the power of light: Researchers refine noninvasive method of bioluminescent optogenetics

by Kelsie Smith Hayduk,University of Rochester(A) Schematic illustration of the LMO7 molecule. (B) Representative histological images showing fluorescence expression in the left SI of a mouse. (
Neurology October 16,2024
Turning brain cells on using the power of light: Researchers refine noninvasive method of bioluminescent optogenetics

Turning brain cells on using the power of light: Researchers refine noninvasive method of bioluminescent optogenetics

by Kelsie Smith Hayduk,University of Rochester(A) Schematic illustration of the LMO7 molecule. (B) Representative histological images showing fluorescence expression in the left SI of a mouse. (
Neurology October 16,2024
Global effort to map the human brain releases first data

Global effort to map the human brain releases first data

byAllen Institute for Brain ScienceBrain slice being prepared for analysis and study. Credit: Erik Dinnel / Allen InstituteThe BRAIN Initiative Cell Atlas Network (BICAN) has launched its first
Neurology October 16,2024
Global effort to map the human brain releases first data

Global effort to map the human brain releases first data

byAllen Institute for Brain ScienceBrain slice being prepared for analysis and study. Credit: Erik Dinnel / Allen InstituteThe BRAIN Initiative Cell Atlas Network (BICAN) has launched its first
Neurology October 16,2024
AlphaFold: The making of a scientific breakthrough

AlphaFold: The making of a scientific breakthrough

The inside story of the DeepMind team of scientists and engineers who created AlphaFold, an AI system that is recognised as a solution to "protein folding", a grand scientific challenge for more than 50 years.
Breakthroughs October 16,2024
AlphaFold: The making of a scientific breakthrough

AlphaFold: The making of a scientific breakthrough

The inside story of the DeepMind team of scientists and engineers who created AlphaFold, an AI system that is recognised as a solution to "protein folding", a grand scientific challenge for more than 50 years.
Breakthroughs October 16,2024
Device offers first affordable, portable method for differentiating stroke risk based on physiological conditions

Device offers first affordable, portable method for differentiating stroke risk based on physiological conditions

byCalifornia Institute of TechnologyCaltech and USC have developed a new laser-based headset device that can noninvasively measure blood flow and volume. Caltech postdoctoral scholar Simon Mahle
Cardiovascular Diseases October 16,2024
Device offers first affordable, portable method for differentiating stroke risk based on physiological conditions

Device offers first affordable, portable method for differentiating stroke risk based on physiological conditions

byCalifornia Institute of TechnologyCaltech and USC have developed a new laser-based headset device that can noninvasively measure blood flow and volume. Caltech postdoctoral scholar Simon Mahle
Cardiovascular Diseases October 16,2024
More News
Week’s Top
Podcasts
... Can AI Catch What Doctors Miss? ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Health spending has been rising across rich countries with different systems ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com